The German pharmaceutical industry reacted sharply on Friday to U.S. President Donald Trump’s announced 100 per cent tariffs on medicines. “If the plans are implemented as announced from October 1, this would be a severe setback for Germany and Europe as pharmaceutical industry locations,” the VFA industry association said. The announcement was at odds with
Don't miss out on breaking stories and in-depth articles.
